Rituximab-Combination Chemotherapy Achieves a 10th Cycle of Remission for Burkitt's Lymphoma

Pediatrics International - United Kingdom
doi 10.1111/ped.12524
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Burkitt's Lymphoma

CA - A Cancer Journal for Clinicians
OncologyHematology
1982English

Treatment With Combination of Lenalidomide and Rituximab Achieves Durable Responses in a Long Term Follow Up of Patients With Indolent Non-Hodgkin's Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Kidney International Reports
Nephrology
2018English

Histological Diagnosis of Burkitt's Lymphoma: A Cautionary Tale.

BMJ
1971English

Burkitt's Lymphoma: A Human Cancer Model

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1986English

Intra-Cardiac Burkitt's Lymphoma

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2005English

Burkitt's Lymphoma in Canada?

BMJ
1968English

Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone Prior to Combination With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Novel Chemotherapy-Free Combination Regimen for Ibrutinib-Resistant Mantle Cell Lymphoma

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy